Replies to Post #88772 onAnavex Life Sciences Corp (AVXL)

Replies to post #88772 on Anavex Life Sciences Corp (AVXL)

Replies to #88772 on Anavex Life Sciences Corp (AVXL)

01/25/17 8:50 PM

#88778 RE: A_Good_Day_2 #88772

The cost of phase2/3 for central nervous system drug cost on average $13,000 per patient.

01/26/17 9:19 AM

#88808 RE: A_Good_Day_2 #88772

You seem to be mixing trials.

As I said....Believe him or not......Rett Grant still not close to even THAT cost.